NM_005506.4:c.275+6495G>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005506.4(SCARB2):​c.275+6495G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.294 in 152,038 control chromosomes in the GnomAD database, including 7,071 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 7071 hom., cov: 32)

Consequence

SCARB2
NM_005506.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.148

Publications

28 publications found
Variant links:
Genes affected
SCARB2 (HGNC:1665): (scavenger receptor class B member 2) The protein encoded by this gene is a type III glycoprotein that is located primarily in limiting membranes of lysosomes and endosomes. Earlier studies in mice and rat suggested that this protein may participate in membrane transportation and the reorganization of endosomal/lysosomal compartment. The protein deficiency in mice was reported to impair cell membrane transport processes and cause pelvic junction obstruction, deafness, and peripheral neuropathy. Further studies in human showed that this protein is a ubiquitously expressed protein and that it is involved in the pathogenesis of HFMD (hand, foot, and mouth disease) caused by enterovirus-71 and possibly by coxsackievirus A16. Mutations in this gene caused an autosomal recessive progressive myoclonic epilepsy-4 (EPM4), also known as action myoclonus-renal failure syndrome (AMRF). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
SCARB2 Gene-Disease associations (from GenCC):
  • action myoclonus-renal failure syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • progressive myoclonus epilepsy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Unverricht-Lundborg syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.455 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCARB2NM_005506.4 linkc.275+6495G>C intron_variant Intron 2 of 11 ENST00000264896.8 NP_005497.1
SCARB2NM_001204255.2 linkc.275+6495G>C intron_variant Intron 2 of 8 NP_001191184.1
SCARB2XM_047416429.1 linkc.-200+6495G>C intron_variant Intron 2 of 11 XP_047272385.1
SCARB2XM_047416430.1 linkc.-200+6495G>C intron_variant Intron 2 of 11 XP_047272386.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCARB2ENST00000264896.8 linkc.275+6495G>C intron_variant Intron 2 of 11 1 NM_005506.4 ENSP00000264896.2

Frequencies

GnomAD3 genomes
AF:
0.295
AC:
44757
AN:
151920
Hom.:
7071
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.206
Gnomad AMI
AF:
0.392
Gnomad AMR
AF:
0.464
Gnomad ASJ
AF:
0.398
Gnomad EAS
AF:
0.364
Gnomad SAS
AF:
0.237
Gnomad FIN
AF:
0.245
Gnomad MID
AF:
0.430
Gnomad NFE
AF:
0.309
Gnomad OTH
AF:
0.335
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.294
AC:
44755
AN:
152038
Hom.:
7071
Cov.:
32
AF XY:
0.293
AC XY:
21784
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.205
AC:
8509
AN:
41472
American (AMR)
AF:
0.464
AC:
7078
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.398
AC:
1380
AN:
3470
East Asian (EAS)
AF:
0.364
AC:
1881
AN:
5172
South Asian (SAS)
AF:
0.237
AC:
1140
AN:
4820
European-Finnish (FIN)
AF:
0.245
AC:
2584
AN:
10558
Middle Eastern (MID)
AF:
0.432
AC:
127
AN:
294
European-Non Finnish (NFE)
AF:
0.309
AC:
20994
AN:
67974
Other (OTH)
AF:
0.334
AC:
705
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1559
3118
4677
6236
7795
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
448
896
1344
1792
2240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.175
Hom.:
360
Bravo
AF:
0.312
Asia WGS
AF:
0.267
AC:
931
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
7.3
DANN
Benign
0.87
PhyloP100
-0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6825004; hg19: chr4-77110365; API